Suppr超能文献

通过表面能表征研究气流粉碎和喷雾干燥多粘菌素粉末雾化行为的变化

Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.

作者信息

Jong Teresa, Li Jian, Morton David A V, Zhou Qi Tony, Larson Ian

机构信息

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.

出版信息

J Pharm Sci. 2016 Mar;105(3):1156-63. doi: 10.1016/S0022-3549(15)00189-6. Epub 2016 Jan 30.

Abstract

This study aimed to investigate the surface energy factors behind improved aerosolization performance of spray-dried colistin powder formulations compared with those produced by jet milling. Inhalable colistin powder formulations were produced by jet milling or spray drying (with or without l-leucine). Scanning electron micrographs showed the jet-milled particles had irregularly angular shapes, whereas the spray-dried particles were more spherical. Significantly higher fine particle fractions were measured for the spray-dried (43.8%-49.6%) versus the jet-milled formulation (28.4%) from a Rotahaler at 60 L/min; albeit the size distribution of the jet-milled powder was smaller. Surprisingly, addition of l-leucine in the spray drying feed solution gave no significant improvement in fine particle fraction. As measured by inverse gas chromatography, spray-dried formulations had significantly (p < 0.001) lower dispersive, specific, and total surface energy values and more uniform surface energy distributions than the jet-milled powder. Interestingly, no significant difference was measured in the specific and total surface energy values between the spray-dried formulation with or without l-leucine. Based on our previous findings in the self-assembling behavior of colistin in aqueous solution and the surface energy data obtained here, we propose the self-assembly of colistin molecules during spray drying contributed significantly to the reduction of surface free energy and the superior aerosolization performance.

摘要

本研究旨在探究喷雾干燥的黏菌素粉末制剂与气流粉碎法制得的制剂相比,其雾化性能改善背后的表面能因素。可吸入性黏菌素粉末制剂通过气流粉碎或喷雾干燥(添加或不添加L-亮氨酸)制备。扫描电子显微镜图像显示,气流粉碎的颗粒呈不规则角状,而喷雾干燥的颗粒更呈球形。在Rotahaler以60 L/min的流速下,喷雾干燥制剂(43.8%-49.6%)的细颗粒分数显著高于气流粉碎制剂(28.4%);尽管气流粉碎粉末的粒径分布更小。令人惊讶的是,在喷雾干燥进料溶液中添加L-亮氨酸并未显著提高细颗粒分数。通过反向气相色谱法测定,喷雾干燥制剂的分散表面能、比表面能和总表面能值显著更低(p < 0.001),且表面能分布比气流粉碎粉末更均匀。有趣的是,添加或不添加L-亮氨酸的喷雾干燥制剂在比表面能和总表面能值上没有显著差异。基于我们之前关于黏菌素在水溶液中的自组装行为的研究结果以及此处获得的表面能数据,我们提出喷雾干燥过程中黏菌素分子的自组装对表面自由能的降低和优异的雾化性能有显著贡献。

相似文献

2
L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Eur J Pharm Biopharm. 2016 May;102:132-41. doi: 10.1016/j.ejpb.2016.02.010. Epub 2016 Mar 9.
3
Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
Mol Pharm. 2018 Sep 4;15(9):4004-4020. doi: 10.1021/acs.molpharmaceut.8b00445. Epub 2018 Aug 3.
4
Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.
J Pharm Sci. 2013 Oct;102(10):3736-47. doi: 10.1002/jps.23685. Epub 2013 Jul 31.
5
Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
Pharm Res. 2022 Nov;39(11):2781-2799. doi: 10.1007/s11095-022-03344-5. Epub 2022 Aug 2.
7
Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols.
Pharm Dev Technol. 2016;21(1):68-75. doi: 10.3109/10837450.2014.971373. Epub 2014 Oct 21.

引用本文的文献

3
Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
Pharm Res. 2022 Nov;39(11):2781-2799. doi: 10.1007/s11095-022-03344-5. Epub 2022 Aug 2.
4
Pulmonary Drug Delivery of Antimicrobials and Anticancer Drugs Using Solid Dispersions.
Pharmaceutics. 2021 Jul 10;13(7):1056. doi: 10.3390/pharmaceutics13071056.
5
Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery.
Pharmaceutics. 2020 Jun 17;12(6):557. doi: 10.3390/pharmaceutics12060557.
6
Physical stability of dry powder inhaler formulations.
Expert Opin Drug Deliv. 2020 Jan;17(1):77-96. doi: 10.1080/17425247.2020.1702643. Epub 2019 Dec 13.
10
Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
Mol Pharm. 2018 Sep 4;15(9):4004-4020. doi: 10.1021/acs.molpharmaceut.8b00445. Epub 2018 Aug 3.

本文引用的文献

1
Inhaled Formulation Design for the Treatment of Lung Infections.
Curr Pharm Des. 2015;21(27):3875-901. doi: 10.2174/1381612821666150820110305.
2
Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.
Curr Pharm Des. 2015;21(27):3902-16. doi: 10.2174/1381612821666150820111134.
3
Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
Adv Drug Deliv Rev. 2015 May;85:83-99. doi: 10.1016/j.addr.2014.10.022. Epub 2014 Oct 24.
4
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
Adv Drug Deliv Rev. 2015 May;85:65-82. doi: 10.1016/j.addr.2014.11.004. Epub 2014 Nov 12.
5
Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
Expert Opin Drug Deliv. 2015 Jun;12(6):947-62. doi: 10.1517/17425247.2015.977783. Epub 2014 Nov 12.
6
Emerging inhalation aerosol devices and strategies: where are we headed?
Adv Drug Deliv Rev. 2014 Aug;75:3-17. doi: 10.1016/j.addr.2014.03.006. Epub 2014 Apr 13.
10
Liposomal formulations for inhalation.
Ther Deliv. 2013 Aug;4(8):1047-72. doi: 10.4155/tde.13.71.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验